Clinical Trial Update: Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating supplementary vitamin D in patients with type 2 diabetes mellitus and pulmonary tuberculosis. Status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Vitamin D (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Type 2 Diabetes Mellitus, Pulmonary Tuberculosis | Phase 4 | Status: UNKNOWN